(19)
(11) EP 4 815 937 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24898710.9

(22) Date of filing: 27.11.2024
(51) International Patent Classification (IPC): 
A61K 31/395(2006.01)
A61K 31/415(2006.01)
A61K 31/33(2006.01)
A61K 31/18(2006.01)
A61K 31/425(2006.01)
(52) Cooperative Patent Classification (CPC):
C09K 8/035
(86) International application number:
PCT/US2024/057645
(87) International publication number:
WO 2025/117661 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 28.11.2023 US 202363603357 P
19.01.2024 US 202463622812 P

(71) Applicant: Quantx Biosciences US, Inc.
Princeton, NJ 08540 (US)

(72) Inventors:
  • HUANG, Xianhai
    Warren, New Jersey 07059 (US)
  • TANG, Haifeng
    Metuchen, New Jersey 08840 (US)
  • SIMON, Adam
    Northridge, California 91324 (US)
  • YANG, Dexi
    Livingston, New Jersey 07039 (US)
  • SUN, Yaxiong
    Thousand Oaks, California 91320 (US)
  • ROYTMAN, Vladislav
    Brooklyn, NY 11209 (US)
  • DUAN, Jingwu
    Yardley, Pennsylvania 19067 (US)

(74) Representative: Maiwald GmbH 
Elisenhof Elisenstraße 3
80335 München
80335 München (DE)

   


(54) BICYCLIC HETEROARYL COMPOUNDS